SAN DIEGO — Aviva Systems Biology Corporation (ASB) which supplies protein research tools, announced the acquisition of GenWay Biotech Incorporated, a protein solutions and applications provider with a comprehensive service and product offering for both the research and diagnostic markets. “This acquisition will facilitate growth and enhance capabilities for both entities. GenWay’s 18 years of experience producing […]

Vancouver, British Columbia Precision NanoSystems is helping scientists to push the boundaries of neuroscience research with a range of efficient and easy-to-use primary cell transfection kits. Combining user-friendly NanoAssemblr™ microfluidics systems with advanced nanoparticle technology, the company has developed the Neuro9™, Astro9™ and iNeuro9™ non-viral gene transfection kits to allow rapid and easy knockdown or […]

Rockville, MD – Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC. (MSD), today launched V-PLEX immunoassays validated for the detection of the biomarkers IL-17A, IL-21, IL-22, IL-23, IL-27, and MIP-3α in human cell culture supernatants, serum, plasma, and urine. As part of several major T-cell-related pathways, these biomarkers are subjects of drug discovery […]

TORONTO–(BUSINESS WIRE)–FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound and photoacoustic imaging systems and subsidiary of FUJIFILM SonoSite, Inc., today announced the launch of its new Vevo LAZR-X, the world’s only customizable imaging platform combining ultra high frequency ultrasound and photoacoustics for animal research applications. Featuring superior image resolution—down to 30 microns—the […]

AMSBIO has introduced a new range of cancer cell line models and culture media for the most difficult to culture tumor types where no models may exist. Alex Sim, Managing Director at AMSBIO said, “Our new partnership with Cellaria Biosciences expands our existing portfolio by introducing patient-derived cancer models; allowing customers to conduct research and drug […]

OMAHA, Neb.–Transgenomic, Inc. (TBIO) (OTCQB: TBIO) today reported that trading in its shares will begin on the OTCQB exchange under the ticker “TBIO” effective at the open of business on February 22, 2017. On February 17, 2017, the Company received written notification from the staff of the Nasdaq Stock Market LLC (“Nasdaq”) that it had […]

CONCORD, Mass.–N-of-One, Inc., founded in 2008 as a leader in interpretation of molecular tests in oncology, announced today the launch of RapidInsights for Illumina’s TruSight Tumor 170 (TST170). RapidInsights is a fully automated interpretation solution that, in a matter of minutes, will read the bioinformatics output of the genomic variants produced by the TST170, and […]

Is now one of the only ISO certified third-party sequencer maintenance and resale companies TORRANCE, Calif. — SeqGen, Inc., a worldwide DNA sequencer and qPCR maintenance and equipment sales company, has achieved International Organization for Standardization (ISO) 9001:2015 certification. Through meeting the standards for this certification, SeqGen has demonstrated its ability to provide products and services […]

AUSTIN, Texas − Asuragen, Inc., a global molecular diagnostics company, announced today that it has entered into a collaboration agreement with Thermo Fisher Scientific for the development and commercialization of capillary electrophoresis-based in vitro diagnostics (IVDs). Asuragen will leverage its AmplideX® PCR/CE product technologies to develop diagnostic kits for the 3500 Dx Series Genetic Analyzer CS2 instrument. […]

Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB’s expansion and relocation which took place in January 2014 […]